Category: M&A

  • Encompass Health Moving Forward with Spinoff Plans, to Rebrand New Business ‘Enhabit’

    In December 2020, Encompass Health Corporation (NYSE: EHC) announced that it was “exploring strategic alternatives” for its home health and hospice segment. The company doubled down on its preferred option on Wednesday. The Birmingham, Alabama-based company announced it intends to spin off the segment into a new publicly traded company under the name “Enhabit Home […]

  • Fulcrum Equity Partners Invests $11M in HomeFirst Home Healthcare

    A young but rapidly growing in-home care business headquartered in Nashville, Tennessee, has secured millions of dollars to further fuel its expansion. The Atlanta-based Fulcrum Equity Partners announced Thursday the investment of $11 million into HomeFirst Home Healthcare, a home-based care platform company formed in September 2020 by a team of home health veterans. The […]

  • Spinoff or Merger: Making Sense of Encompass Health’s Options

    Activist investment firm Jana Partners is reportedly urging Encompass Health Corporation (NYSE: NYSE) to reconsider plans to spin off its home health and hospice segment into a new public entity. Instead, Jana wants the Birmingham, Alabama-based company to circle back to a potential third-party merger. There are hypothetical advantages and disadvantages to both a public […]

  • These 8 Deals from 2021 Will Shape the Future of Home-Based Care

    With all eyes focused on the home, it’s no exaggeration to say there were dozens of blockbuster in-home care acquisitions last year. But while all transactions directly impact the buyers and sellers, only a handful help shape the trajectory of an entire market. As I started to think about my own home health and home […]

  • Another mRNA company gets snapped up as Merck buys Exelead

    The latest pharma company to make a move for an mRNA specialist is Germany’s Merck KGaA, which has offered a $780 million cash buyout to US biotech Exelead. Unlike other recent deals however the takeover isn’t focused on adding a pipeline of mRNA candidates, as Indianapolis-based Exelead is a contract development and manufacturing organisation (CDMO) […]

  • Addus Lands JourneyCare for $85 Million

    Addus HomeCare Corporation (Nasdaq: ADUS) had intended to focus largely on home health and personal care acquisitions in 2022. But when a good hospice deal comes along, it’s difficult to pass up. The Frisco, Texas-based Addus announced Wednesday that it has reached an agreement to acquire “substantially all the assets of” Glenview, Illinois-based JourneyCare for […]

  • Post-Acute Data Analytics Company Trella Health Acquires PlayMaker Health

    Trella Health, a post-acute care data analytics company, announced Tuesday that it has acquired PlayMaker Health. “[The home-based care industry] has been asking for this,” J. Scott Tapp, president and CEO of Trella, told Home Health Care News. “Instead of having multiple vendors, they wanted a single [organization] that they could turn to.” Atlanta-based Trella […]

  • Square Health merger throws telehealth firm Push Doctor a lifeline

    Push Doctor – a digital platform that virtually connects patients with GPs – has been acquired by private healthcare service provider Square Health for an undisclosed fee. Rumours of a deal first emerged last November, amid reports that Push Doctor had been at risk of insolvency and going into administration. The company reported a loss […]

  • Homecare Homebase Parent Company Hearst Strikes Deal for CellTrak

    Last April, Addus HomeCare Corporation (Nasdaq: ADUS), Homecare Homebase (HCHB) and CellTrak announced they were teaming up to build “the industry’s first integrated, enterprise-level solution for all types of home-based care.” The next big step in that collaboration has come for two of those organizations. Hearst, the parent company of HCHB, has struck an agreement […]

  • Armed with Bigger Balance Sheet, Care Advantage Delivering on ‘Assertive’ M&A Strategy

    The Richmond, Virginia-based home care provider Care Advantage Inc. went through a dealmaking lull during the early days of COVID-19. Unfortunately, the pandemic has not yet completely subsided. But that lull certainly has. On Dec. 29, Care Advantage announced it acquired Dover, Delaware-based Silver Lining Home Healthcare. With the deal, the company has made three […]

  • Novartis adds gene therapy for blindness with Gyroscope buy

    Gyroscope Therapeutics and its gene therapy for the sight-robbing disease geographic atrophy (GA) has been acquired by a big pharma company – but likely not the one you would expect. Just a few weeks France’s Sanofi made a $40 million investment in Gyroscope for first refusal rights on the gene therapy – called GT005 – […]

  • The Top 10 Home Health Care News Stories of 2021

    The public health emergency continued to have an impact on home-based care providers in 2021. It didn’t define the year, however. As the top Home Health Care News stories of 2021 suggest, this year was about so much more than the COVID-19 crisis. Even more than the pandemic, the past 12 months have been about […]

  • Sanofi buys US immuno-oncology biotech Amunix for $1 billion

    Sanofi has bolstered its immuno-oncology pipeline with a $1 billion agreement to acquire Amunix Pharma of the US – its fourth bolt-on deal of 2021. South San Francisco-based Amunix specialises in T-cell engager and cytokine-based treatments for solid tumours, and is planning to advance its lead programme AMX-818 – a cell-based therapy which targets HER2-expressing […]

  • Oracle to buy Cerner for $28.3B 

    The companies struck an all-cash deal on Monday for $95-per share. Oracle plans to add a voice interface to Cerner’s electronic health record system. 

  • DispatchHealth Makes Second Acquisition, Buys Dynamic Mobile Imaging

    In a move to further cement its growing mobile diagnostics services, DispatchHealth announced Tuesday that it has acquired Dynamic Mobile Imaging. The financial terms of the transaction were not disclosed. “Our industry-transforming vision at DispatchHealth is to create the world’s largest in-home care system and ensure convenient, safe and lower-cost medical care,” COO Shannon Werb […]

  • Australia’s CSL makes $11.7bn bid for Swiss pharma Vifor

    Australian biotech group CSL has agreed a deal to acquire Swiss drugmaker Vifor Pharma in an all-cash deal that expands its speciality medicines business. If it goes through, the merger will allow CSL to diversify its business which is focused mainly on plasma-derived medicines sold by its CSL Behring unit and vaccines under the Seqirus […]

  • Flush with COVID cash, Pfizer tables $6.7bn bid for Arena

    Pfizer has found another use for the windfall profits it is making from it BioNTech-partnered COVID-19 vaccine, agreeing to buy Arena Pharma and its late-stage ulcerative colitis drug etrasimod. The $100-per-share deal values Arena at around $6.7 billion, and gives Pfizer an entry into the oral S1P receptor modulator category that puts it in contention […]

  • Home Care Transaction Volume Is ‘Unsustainable,’ Likely to Taper Off Next Year

    The home-based care M&A landscape has been very active over the last year. And as long as the publicly traded companies remain in good standing, investment activity from private equity players and others is likely to remain strong. That’s according to Mertz Taggart Managing Partner Cory Mertz, who said at the Home Health Care News […]

  • AI-based drug discovery firm BenevolentAI cuts SPAC deal

    UK artificial intelligence specialist BenevolentAI has said it will float on the Amsterdam Euronext exchange in what is being touted as Europe’s largest ever special purpose acquisition company (SPAC) deal. BenevolentAI will merge with Odyssey Acquisition, a SPAC set up by investment bankers Michael and Yoel Zaoui that lists former Sanofi chief executive Olivier Brandicourt […]

  • Did AZ scupper Sobi’s $8bn private equity buyout?

    An $8 billion attempt by two private equity companies to acquire Swedish rare disease specialist Sobi and take it back into private ownership has collapsed, with reports suggesting AstraZeneca was instrumental in blocking the deal. Tenders to the offer fell below the 90% threshold needed to drive the merger through, and a key part of […]

  • ‘It’s Back to Basics’: Home Health Giants Share Staffing Strategies, Growth Goals

    This article is an exclusive feature available as a part of your subscription to HHCN + Basically all of the publicly traded in-home care giants offered internal updates and expectations for the coming year this week during a series of investor presentations. In addition to company-specific plans, the group discussed key policy developments and important […]

  • How Aveanna Has ‘Materially Changed’ Its Business After Going Public

    When Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) became a public company earlier this year, it expressed the desire to expand its reach past pediatric home health to seniors. While there were some skeptics within the industry on how feasible that would be, the Atlanta-based company has done an impressive job executing on that strategy thus […]

  • Sanofi snaps up acne vaccine developer Origimm Bio

    Sanofi has added to its vaccine pipeline with an agreement to acquire Austria’s Origimm Biotechnology and its vaccine-based immunotherapy for people with acne. The French group said that ORI-001, a vaccine based on recombinant proteins from the  Cutibacterium acnes (formerly Propionibacterium acnes) bacterium that is often found in acne lesions, could be the first ever […]

  • Transactions: Riverside Invests in Executive Care; Charter Buys Silver Linings Hospice Care

    Home care provider Executive Care recently received an investment from global investment firm The Riverside Company. The financial terms were not disclosed. Hackensack, New Jersey-based Executive Care is a private-pay personal care company that operates a network of 13 franchise locations and offers a plethora of services, including companionship, homemaking, personal care and live-in care. […]

  • Novartis may have found a buyer for Sandoz; report

    Just a few weeks after Novartis revealed it was considering a sale of its generics business Sandoz, there are reports that a potential buyer has already come forward. A report by German newspaper Handelsblatt says that investment group EQT and the German Struengmann family are considering a CHF 20 billion ($21.6 billion) bid for Sandoz […]

  • Vifor builds in kidney disease with Sanifit, Inositec buys

    On the heels of a late-stage clinical trial failure, Vifor Pharma has moved to bolster its pipeline by acquiring Spain’s Sanifit and fell Swiss biotech Inositec for a combined value of €225 million (around $254 million) upfront. The deals mean Glattbrugg-based Vifor claims a clinical-stage drug for patients with complications of end-stage chronic kidney disease […]

  • Is digital health giant Athenahealth heading for new ownership?

    In 2018, the takeover of Athenahealth by Veritas Capital and Elliott Management for $5.5 billion was the biggest digital health transaction of the year, but it could be dwarfed by their exit deal. It’s being rumoured that two other private equity groups – Bain Capital and Hellman & Friedman LLC – are in the final […]

  • Novo Nordisk to Acquire Dicerna for ~$3.3B

    Shots: Novo Nordisk to acquire all outstanding shares of Dicerna common stock for $38.25/share in cash making a total equity value of ~$3.3B representing a premium of 80% to Dicerna’s closing price on Nov 17, 2021. The transaction is expected to close in the Q4’21 The acquisition will utilize Dicerna’s GalXC technology platform to expand […]

  • Novo Nordisk snaps up RNAi partner Dicerna in $3.3bn takeover deal

    Danish drugmaker Novo Nordisk must like what it has seen in its two-year-old alliance with gene-silencing specialist Dicerna Pharma – it has just agreed to acquire the biotech for $3.3 billion in cash. The two companies have been working together since 2019 to develop multiple RNA interference (RNAi) candidates for disorders such as non-alcoholic steatohepatitis […]

  • Aveanna Rockets Past M&A Goals, But ‘Choppy’ Labor Market Remains Challenging

    Not so long ago, in-home care providers like Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) had to basically beg their payers for rate increases or additional resources. “In the old days, we would literally be calling the payer’s rep, you know, begging for another $2 an hour to get a family home,” Aveanna COO Jeff Shaner […]

  • Why Finding a Home Health Provider to Acquire Has Become Tougher

    When Coltala Holdings acquired a stake in Choice Health at Home in June, its co-founders – Ralph Manning and Edward Crawford – were ecstatic. After all, the Dallas-based private equity firm was looking to enter into the home health industry, but wasn’t sure it would be able to. Its confidence in finding the right provider […]

  • AcelRx to Acquire Lowell for ~$32.5M

    Shots: AcelRx signs a merger agreement to acquire Lowell for $32.5M in cash and an additional ~$26.0M in contingent consideration upon the achievement of regulatory and sales-based milestones, $3.5M in AcelRx common stock, ~$6.5M is expected to be issued to Lowell security holders at closing. The transaction is expected to close in Q4’21 The acquisition […]

  • Transactions: Help at Home Acquires Prime Home Care; New Day Healthcare Secures $55.5M

    Chicago-based Help at Home has acquired Prime Home Care, an in-home care provider that offers both home health and home care services across nine Ohio locations, including the large markets of Columbus, Toledo and Cincinnati. Headquartered in Maineville, Ohio, Prime has been delivering home-based care to clients since 2006. The company currently serves about 900 […]

  • J&J finally decides to dismantle its diversified business model

    After decades of a diversified healthcare business model, Johnson & Johnson has announced it plans to split off its consumer health division from its pharma and medical device operations. The move would create a new consumer health company within 18 to 24 months, according to J&J, which said it would unlock “significant value” whilst allowing […]

  • Organon to Acquire Forendo for ~$954M

    Shots: Organon to acquire Forendo for a total consideration of $954M including $75M up front, $9M in Forendo debt, $270M upon the achievement of development & regulatory milestones & is eligible to receive $600M in commercial milestones payments. The transaction is expected to close in Dec’21 The acquisition adds a pipeline of products targeting novel […]

  • Coloplast to Acquire Atos Medical for ~$2.49B

    Shots: Coloplast to acquire Atos Medical for an enterprise value of $2.49B from PAI Partners. The transaction is expected to close in Q2’22 Coloplast obtains access to a new chronic care segment to be run as a separate strategic business unit operating on shared Coloplast infrastructure that also supports its offerings in urology, continence and […]

  • Alcon to Acquire Ivantis for ~$475M

    Shots: Ivantis to receive $475M up front along with additional payments upon achievement of regulatory & commercial milestones. The transaction is expected to close in Q1’22 The acquisition expands Alcon’s surgical portfolio & uses the commercial execution expertise across cataract, refractive, retina & glaucoma. Hydrus Microstent is approved for use in conjunction with cataract surgery […]

  • Swiss socialists say government should buy Sandoz

    Switzerland’s Social Democratic Party has argued that the government should step in and acquire Novartis’ generics unit Sandoz if the company decides to sell it, according to local press reports. The largest left-leaning party in Switzerland said that national ownership of Sandoz would democratise the production and development of new medicines, maintain a stable supply […]

  • HouseWorks Enters the Medicaid Personal Care Sector with Connected Home Care Acquisition

    HouseWorks announced Thursday that it has signed an agreement to acquire Connected Home Care, a home care provider that operates in Eastern Massachusetts. The Connected Home Care acquisition comes just one week after HouseWorks’ announced it purchased Atlantic Homelife Senior Care, a private home care provider that operates in Seacoast New Hampshire and Southern Maine. […]

  • Novartis finally sells Roche stake, for almost $21 billion

    After more than 20 years, Novartis has finally decided to sell its substantial share in fellow Swiss pharma group Roche for $20.7 billion, a decent return on its original $5 billion investment. The agreement will see Novartis lose its one-third voting share stake in Roche, after agreeing to sell 53.3 million Roche bearer shares at […]

  • Lonza Collaborates with Codiak to Acquire its Exosomes Manufacturing Facility in Lexington, Massachusetts (US)

    Shots: Codiak to receive $65M of in-kind manufacturing services for its clinical-stage programs and hold its pipeline of therapeutic candidates along with exosome engineering and loading technologies Lonza will obtain global access and sub-licensable rights of Codiak’s high-throughput perfusion-based cGMP process for exosome manufacturing The companies established a center of excellence to develop exosome manufacturing […]

  • Addus Prioritizing Staff Vaccinations with CMS, OSHA Mandates Looming

    In terms of financial results, Addus HomeCare Corporation (Nasdaq: ADUS) is coming off a record third quarter. The Frisco, Texas-based home health, hospice and personal care services provider has plenty of challenges ahead, however, including the difficult labor landscape that’s about to become even more complex thanks to federal COVID-19 vaccination rules. Somewhat diminished M&A […]

  • AlayaCare Acquires Delta Health Technologies, Accelerates Medicare Home Health Strategy in US

    Home-focused software and technology company AlayaCare has acquired Delta Health Technologies, a provider of home health solutions. Traditionally a home care software enabler, this acquisition accelerates a strategy that AlayaCare has been honing in on: expanding significantly into the U.S. Medicare home health market. “Our platform does lots of skilled care in other markets,” AlayaCare […]

  • Takeda buys GammaDelta to boost cancer cell therapy credentials

    Japanese drugmaker Takeda has said it will exercise its option to buy UK-based GammaDelta Therapeutics, a specialist in ‘off-the-shelf’ cell therapies for solid tumours and blood cancers. The two companies have been working together since 2017, with Takeda pledging $100 million to help GammaDelta advance its cell therapy platform as part of a “build-to-buy” arrangement. […]

  • Takeda to Acquire GammaDelta to Advance the Development of Allogeneic γδT Cell Therapies for the Treatment of Solid Tumors

    Shots: Takeda exercises its option to acquire GammaDelta which includes up front along with development and regulatory milestones. The acquisition is expected to be close in Q1’22 The acquisition follows a 2017 collaboration b/w Takeda & GammaDelta to develop GammaDelta’s novel γδ T cell therapy platforms. Takeda will obtain GammaDelta’s allogeneic Vδ1 gamma-delta (γδ) T […]

  • Beyond the Bottom Line: Why M&A Isn’t Just About EBITDA for The Pennant Group

    Over two years after spinning off from The Ensign Group (Nasdaq: ENSG), Eagle, Idaho-based The Pennant Group (Nasdaq: PNTG) stands at 87 home health and hospice agencies, plus 54 senior living communities. The company has locations throughout 14 states overall. The Pennant Group is, no doubt, a large-scale provider with plenty of resources at its […]

  • Intrepid USA Planning for Major Growth Push with New PE Partners

    When putting together a list of home health giants, Intrepid USA Healthcare Services sometimes gets overlooked. The Texas-based Intrepid USA has more than 60 locations spanning 17 states and a company history that goes back over five decades, but it mostly operates in rural areas. Its CEO, John Kunysz, often refers to Intrepid as a […]

  • Novartis looking into future of its Sandoz’ generics business

    Novartis revealed today that it may consider divesting its generic medicines subsidiary Sandoz – amongst other options – which would further narrow its focus to innovative medicines. The company said in its third-quarter results statement that it was weighing options for Sandoz to “maximise shareholder value,” adding that could include retaining the business or a […]

  • HouseWorks Lands Atlantic Homelife Senior Care; Help at Home Completes Multiple Acquisitions

    The independent home care company HouseWorks has acquired Atlantic Homelife Senior Care. Financial terms of the transaction were not disclosed. Headquartered in Boston, HouseWorks offers mainly private-pay in-home care services to older adults in Massachusetts and New Hampshire, plus Philadelphia and parts of Maine. In addition to traditional home care services, HouseWorks — founded more […]

  • Increasing Supply Fueling Home Health, Home Care Transactions

    A greater supply of home health and home care businesses is fueling an increase in dealmaking activity, according to the latest M&A update from advisory firm Mertz Taggart. That’s also true for hospice transactions. Overall, there were at least 44 home health, home care and hospice deals in the third quarter of 2021, three more […]

  • Acceleron investors dig their heels in on Merck takeover bid

    Activist investors are pushing back against Merck & Co’s recent $11.5 billion deal to acquire Acceleron Pharma, arguing that its $180-per-share offer seriously undervalues the company. Avoro Capital, Holocene Advisors and Darwin Global are all arguing that Acceleron should hold off on a sale for several upcoming developments that they maintain could dramatically increase vale. […]

  • Alpine Investors-Backed TEAM Services Group Acquires 24 Hour Home Care

    TEAM Services Group – a portfolio company of the “anti-private equity firm” Alpine Investors – has acquired 24 Hour Home Care. The exact details of TEAM’s investment in the Los Angeles-based home care company have not yet been disclosed. 24 Hour Home Carewill continue operating by the same name under TEAM’s “Public Choices” division. Alpine […]

  • Hologic to Acquire Bolder Surgical for $160M

    Shots: Hologic to acquire Bolder Surgical for ~$160M which is a provider of advanced energy vessel sealing surgical devices. The acquisition is expected to be closed by 2021 The transaction will add laparoscopic vessel sealing, dividing and dissecting devices to the Hologic portfolio and enable it to expand the use of Bolder’s devices to OB/GYN specialists The […]

  • Best Buy Acquires At-Home Care Tech Platform Current Health

    Best Buy (NYSE: BBY) has signed an agreement to acquire the home-focused technology platform Current Health in an effort “to help make home the center of health,” according to the company. Along with the likes of Amazon (Nasdaq: AMZN) and Walmart (NYSE: WMT), Best Buy has been one of the retail giants that has steadily […]

  • Supernus bulks up its Parkinson’s portfolio with Adamas takeover

    Supernus has boosted its position in central nervous system therapies with a $400 million deal to acquire Adamas Pharma that will add two approved Parkinson’s disease therapies to its stable. The deal will diversify Supernus’ revenues and reduce its reliance on Trokendi XR (topiramate), a drug for migraine prevention and epilepsy that currently accounts for […]

  • Pacira to Acquire Flexion for ~427M

    Shots: Pacira Signs a definitive agreement to acquire Flexion for $8.50/share in cash along with one non-tradeable CVR of ~$8.00/share in cash upon the achievement of sales & regulatory milestones. The transaction is expected to close in Q4’21 The acquisition will support Pacira to expand its leadership position in non-opioid pain management with the addition […]

  •  Why Virgin Pulse bought Welltok

    The merger of the two patient engagement companies will create an organization with more than 2,000 employees. The deal would expand Virgin Pulse’s channels for communicating with patients and help it expand into some new markets. 

  • Supernus to Acquire Adamas for ~$450M

    Shots: Supernus signs a definitive agreement to acquire Adamas for $8.10/ share in cash (~$400M) & 2 non-tradable CVR of ~$1.00 00/share in cash (~$50M) based on sales of GOCOVRI, making a total deal value of $9.10/share in cash (~$450M). The transaction is expected to close in Q4’21 or Q1’22 The 1st & 2nd CVR […]

  • Boston to Acquire Baylis for ~$1.75B

    Shots: Boston has entered into a definitive agreement to acquire Baylis for $1.75B up front. The transaction is anticipated to close in Q1’22 The acquisition will bolster Boston’s electrophysiology and structural heart product portfolios with the addition of Baylis’ platforms i.e., NRG and VersaCross Transseptal that uses radiofrequency to access the left side of the heart […]

  • Inotiv to Acquire Plato BioPharma for ~$15.0M

    Shots: Inotiv to acquire Plato BioPharma for $15.0M that consist of $10.0M in cash, $2.0M in Inotiv’s common shares (57,587) based on the average closing price for 20 trading-day period ends on Sept 29, 2021, $3.0M in unsecured promissory notes The acquisition will bolster PBI’s growing discovery operations in the Boulder, Colorado & expands its […]

  • Pharos Capital Adds to Growing Home-Based Care Portfolio with THEMA Acquisition

    Private equity firm Pharos Capital Group has acquired THEMA Health Services, a home health and palliative care provider that operates across Arizona. The financial terms of the transaction were not disclosed. Prescott, Arizona-based THEMA provides care services including home health, palliative care, and hospice in patients’ homes, skilled nursing facilities, and assisted living facilities. The […]

  • Merck to Acquire Acceleron for ~$11.5B

    Shots: Merck to acquire Acceleron for $180/share in cash making a total equity value of ~$11.5B representing a premium of 2.6% to the stock’s closing price. The transaction is expected to close in Q4’21 The acquisition will strengthen Merck’s cardiovascular pipeline. Acceleron’s sotatercept is currently in P-III trials & has the potential to improve short-term […]

  • Merck confirms $11.5bn Acceleron takeover deal

    After days of speculation, Merck & Co confirmed today that it has agreed to acquire Acceleron Pharma $1.5 billion, setting up what could be one of the largest biopharma acquisitions of 2021 so far. The $180-per-share deal – if completed – will give Merck a pair of blockbuster drug candidates, one of which is already […]

  • AstraZeneca to Acquire Caelum for ~500M

    Shots: Alexion has exercised its option to acquire all remaining equity in Caelum for CAEL-101 which is currently being evaluated in P-III CARES clinical program that consists of 2 P-III trials in combination with SoC therapy for AL amyloidosis Caelum to receive ~$150M as an option exercise fee in addition to ~$350M upon the achievement […]

  • AZ claims full control of Caelum’s AL amyloidosis drug in $500m deal

    AstraZeneca’s newly acquired Alexion will buy the remaining equity in rare disease specialist Caelum Biosciences in a deal that could be worth up to $500 million. The deal gives the Anglo-Swedish drugmaker complete control of Caelum’s late-stage medicine for light chain (AL) amyloidosis, a potentially fatal disease that causes the rogue protein amyloid to build […]

  • Rumour mill says Acceleron is speeding towards $11bn sale

    US biopharma company Acceleron is the next company heading for a takeover by a big pharma group – according to a Bloomberg report citing people close to the matter. Rumours of a deal have been bubbling away for a few days, driving Acceleron’s stock upwards, even before Bloomberg reported that a large pharma group is […]

  • GE Healthcare to Acquire BK Medical for ~ $1.45B

    Shots: GE has signed an agreement to acquire BK Medical for $1.45B in cash and is eligible to receive a high-single-digit return on invested capital within 5yrs. The transaction is expected to close in 2022 The acquisition will allow GE Healthcare to expand its $3B ultrasound business from diagnostics into surgical & therapeutic interventions. The […]

  • Transactions: LHC Group Expands Footprint; Senior Helpers Acquires New Corporate Store

    The LHC Group Inc. (Nasdaq: LHCG) M&A run continues. The Lafayette, Louisiana-based company recently announced agreements to acquire Generations Home Health along with Freda H. Gordon Hospice and Palliative Care, both in Virginia Beach, Virginia. LHC Group expects $7 million in annual revenue from the deals. Sign up for HHCN + to read this exclusive […]

  • Boehringer buys Abexxa, bolstering its immuno-oncology pipeline

    Boehringer Ingelheim says it has agreed to buy US biotech Abexxa Biologics, its second acquisition in the cancer immunotherapy area in the space of a year. Texas-based Abexxa has been on the Boehringer’s radar since it was set up, as it provided seed funding for the preclinical-stage company in 2016, buying into its approach of […]

  • Boehringer Ingelheim Acquires Abexxa to Expands its Immuno-oncology Research

    Shots: The acquisition includes upfront, milestones, and other consideration payments. Abexxa will continue to operate in the Arlington The acquisition will allow Boehringer to access Abexxa’s expertise and capabilities in targeting cancer-specific proteins by using its technology to develop cancer immunotherapies and Abs for solid cancers The acquisition also bolsters Boehringer’s commitment to identifying the […]

  • Boston to Acquire Devoro for ~$336M

    Shots: Boston currently holds ~16% equity stake in Devor & acquires the remaining 84% for ~$269M up front and ~$67M upon achievement of clinical & regulatory milestones. The transaction is expected to close in Q4’21 The acquisition will advance the peripheral interventions portfolio with the addition of Devoro’s WOLF thrombectomy platform to improve procedural efficiencies […]

  • Novartis to Acquire Arctos to Boost its Optogenetics Portfolio to Treat Eye Diseases

    Shots: The acquisition expands Novartis’ ophthalmology portfolio with the addition of Arctos’ pre-clinical optogenetics-based AAV gene therapy program and its technology The acquisition marks the Novartis commitment to identify optogenetics-based therapies for the treatment of patients with vision loss Arctos has developed its technology to treat IRDs and other diseases that involve photoreceptor loss, such […]

  • Vectura investors ignore critics and back tobacco giant takeover

    Tobacco giant Philip Morris International (PMI) has won the shareholder vote it needed for its controversial £1.1 billion takeover of respiratory drugmaker Vectura, despite mobilised opposition to the deal. PMI said it had won support from enough shareholders that – when added to its own holding in Vectura – it had a 75% position in […]

  • Flywheel raises $22M, buys competitor

    After closing a series C round led by 8VC, Flywheel used a portion of the funds to acquire St. Louis-based Radiologics. Both have platforms to help researchers process medical imaging data. 

  • AbCellera Acquires TetraGenetics to Enhance its Capabilities for Developing Antibodies

    Shots: AbCellera acquires TetraGenetics in an all-cash transaction that includes up front, milestones based on the achievement of technical milestones related to the development of therapeutics The acquisition will combine TetraGenetics’ capabilities with AbCellera’s technology to provides an optimized protein source for AbCellera’s Abs discovery across a range of therapeutic areas. The technology has the […]

  • Ginkgo Going Public with ~1.63B in Proceed Via Soaring Eagle SPAC Merger

    Shots: The merger was approved in a shareholder vote with 75% participation & 97% in favor of the combination. Upon the closing of the merger, Ginkgo is eligible to receive ~1.63B in gross proceeds including $775M from a PIPE and ~$858M from the Soaring Eagle trust account Soaring Eagle will now change its name to […]

  • AzurRx Signs a Reverse Triangular Merger Agreement to Acquire First Wave Bio for ~$229M

    Shots: AzurRx to acquire First Wave Bio for $229M in cash & stock including development, regulatory & sales milestones. The transaction is anticipated to close imminently The acquisition will boost AzurRx’s GI pipeline including three new clinical IBD indications for UPS, UC & CD. In Jan’21, AzurRx in-licensed an exclusive global right to develop two […]

  • ZOLL to Acquire Itamar for ~$538M

    Shots: ZOLL Medical to acquire all outstanding ordinary shares of Itamar Medical for $31/ADS or $1.03/ordinary share in cash making a total deal value of $538M representing a premium of 50.2% for $31/ADS to the stock’s last closing price on Sept 10, 2021. The transaction is expected to close at the end of 2021 The […]

  • Roche to Acquire TIB Molbiol for Bolstering its Molecular Diagnostics Portfolio

    Shots: Roche has signed a purchase agreement to acquire 100% of the outstanding shares of the TIB. The transaction is expected to close in Q4’21 The acquisition will bolster Roche’s PCR test portfolio of molecular diagnostics solutions with the addition of multiple assays for infectious disease TIB Molbiol currently has 45+ CE-IVD marked tests and […]

  • ‘The Fittest Survive’: HHVBP Expansion Could Drive Home Health Consolidation

    In the U.S. Centers for Medicare & Medicaid Services’ (CMS) proposed payment rule for 2022, the attention-grabber was the expansion of the Home Health Value-Based Purchasing (HHVBP) Model, the details of which excited some providers and left others concerned. While the specifics of the expansion plan were being discussed during the public comment period, however, […]

  • ICU Medical Commits to Acquire Smith for ~$2.35B

    Shots: Smiths to receive 2.5M at closing in cash and stock which is currently valued at ~$500M, $1.85B in cash along with liabilities & is eligible for up to $100M in milestones. The transaction is expected to close in H1’22 The acquisition combines Smiths’ business includes syringes, ambulatory infusion devices, vascular access & vital care […]

  • LHC Group to Acquire Home Health Assets in 22 States from HCA-Brookdale Venture

    LHC Group Inc. (Nasdaq: LHCG) has already hit a record year for M&A activity. It added to its streak in a major way on Wednesday, announcing an agreement to purchase Brookdale Health Care Services agencies in 22 states from the recently formed venture between Brookdale Senior Living Inc. (NYSE: BKD) and HCA Healthcare (NYSE: HCA). […]

  • Sanofi snaps up Kadmon and its transplant drug Rezurock

    Less than a month after Kadmon Pharma launched its first product – Rezurock for a complication of organ transplants – the New York company has agreed to be bought by Sanofi in a $1.9 billion deal. The merger agreement, which has been agreed by the boards of both companies, will see Sanofi pay $9.50 per […]

  • Sanofi to Acquire Kadmon for ~$1.9B

    Shots: Sanofi to acquire Kadmon for $9.50/share in cash making a total equity value of ~ $1.9B with a premium of 79% to a closing price of $5.30 on Sept 07, 2021. The acquisition is expected to be completed in Q4’21 The acquisition will bolster Sanofi’s transplant business with the addition of Kadmon’s Rezurock to […]

  • Hybrigenics says it wants a merger with Bone Therapeutics

    French biopharma company Hybrigenics has made another bid to merge with Belgium’s Bone Therapeutics, a specialist in regenerative medicine that is still recovering from a setback in its lead development programme. Hybrigenics said in a press release today that it had started discussions with Bone Therapeutics, but the Belgian company was quick to come out […]

  • Advent and GIC to Acquire Sobi for ~$8B

    Shots: Advent and GIC to acquire Sobi for ~$8B (SEK 69.4B) at $27.33/share (SEK 235) representing a premium of 34.5% to the closing price of $20.41. The offer acceptance period is expected to start on Sept 2021 and expire on Oct 21, 2021 Sobi focuses on delivering innovative therapies and services in the areas of […]

  • Abbott to Acquire Walk Vascular to Bolster its Peripheral Vascular Offerings

    Shots: The acquisition will accelerate Abbott’s vascular portfolio with the addition of Walk Vascular’s peripheral thrombectomy systems to treat patients with peripheral blood clots Walk Vascular’s JETi & JETi AIO peripheral thrombectomy systems are aspiration systems for the removal of intravascular clots. The systems are supported by RWE, and Walk is currently enrolling ~250 patients […]

  • Baxter to Acquire Hillrom for ~$10.5B

    Shots: Baxter to acquire Hillrom for $156.00/ share in cash making a total equity value of ~$10.5B representing a premium of 26% to the stock’s closing price of $124 and a total enterprise value of ~ $12.4B, including the assumption of debt. The acquisition is expected to be closed in early 2022 The acquisition will […]

  • Value-Based Care, PDGM Sparks Home Health Dealmaking Activity

    The home health market has been a hotbed of M&A activity as of late, and there are a number of key factors sparking the dealmaking interest. Since its implementation in 2020, the Patient-Driven Groupings Model (PDGM) has loomed large in the home health space. Now, PDGM is a driving force behind much of the transaction […]

  • Provider-Vendor Hybrid PathWell Acquires Caring Angels Home Health

    The home health company PathWell began as a technology company aiming to help other operators with back-end issues. But when COVID-19 hit, it changed direction to become a provider itself, equipped with the capabilities it once exclusively sought to give to others. PathWell has now grown into a multi-state provider through expansion and acquisitions. And […]

  • Baxter in Talks to Acquire Hill-Rom for ~$10B

    Shots: Baxter in talks to acquire Hill-Rom for ~$10B with $150/ share representing a premium of 13% to the stock’s closing price of $132.90. The acquisition is expected to be announced later this week The decision follows an earlier bid in which Hill-Rom had turned down Baxter’s previous offer of $144/ share with a total […]

  • Digital mental health firms Headspace and Ginger in $3bn merger

    A merger between two digital mental health companies – Headspace and Ginger – will create a $3 billion giant in a category that has been growing at breakneck speed as a result of the COVID-19 pandemic. The deal brings together Headspace’s meditation and mindfulness app – used by millions of people around the world – […]

  • Pfizer vaults into CD47 arena, buying Trillium for $2.3 billion

    Pfizer is the latest big pharma company to take a position on drugs that target CD47 – a ‘don’t eat me’ signal that protects cancer cells from being attacked by the immune system. The drugmaker has agreed a $2.3 billion deal to buy Canadian biotech Trillium Therapeutics and its two lead candidates – TTI-622 and […]

  • Pfizer to Acquire Trillium for ~$2.26B

    Shorts: Pfizer will acquire all outstanding shares of Trillium for $18.50/share in cash making a total equity value of $2.26B with 203.8% premium on the stock’s last closing price The acquisition will bolster Pfizer’s R&D capabilities & accelerates clinical development of Trillium’s SIRPα fusion proteins i.e., TTI-622 & TTI-621 that are currently in P-Ib/II trial […]

  • Years after Pfizer merger, ex-Medivation exec gets insider trading charge

    A Medivation executive at the heart of the company’s team that sold the company to Pfizer for $14 billion five years ago is facing allegations of insider trading. Matthew Panuwat A complaint filed by the US Securities and Exchange Commission (SEC) today accuses Matthew Panuwat, the then-head of business development at Medivation, of buying sizeable […]

  • How to Avoid Home Health Dealmaking Landmines

    Interest in acquisitions, mergers and joint venture arrangements continues to heat up in the home health space. But for every successful deal that’s closed, there’s another that ultimately ends up falling apart. While dealmaking landmines will always be present, smart home health providers can often work around trouble if they know where to step. Overall, […]

  • Aveanna Applauds 2022 Proposed Payment Rule, Sets Sights on Home Health Growth

    In the wake of going public in the spring, the leadership team at Aveanna Healthcare Holdings Inc. (Nasdaq: AVAH) has been especially vocal about its appetite for major growth. The company’s leaders echoed this sentiment, highlighting a focus on home health in particular, during its Q2 2021 earnings call on Thursday. “Home health and hospice […]

  • Why Medtronic decided to move now on its $1.1B Intersect ENT deal 

    Investors had long expected Intersect ENT to be an acquisition target before Medtronic announced its plans to buy the company last week. Better reimbursement for Intersect ENT’s products and elective procedures returning over the summer months might have helped the deal cross the finish line. 

  • Sharecare Acquires CareLinx from Generali in $65M Deal

    Last year, CareLinx entered a new phase of its business with its entrance into the clinical side of home-based care. As a result, CareLinx saw major growth, which, in turn, made the company more attractive to prospective buyers. One of those interested parties has officially made a play for CareLinx. On Tuesday, Sharecare (Nasdaq: SHCR) […]

  • The Pennant Group Holds Firm on Home Health Growth Strategy Amid Labor, COVID-19 Challenges

    The Pennant Group Inc.’s (Nasdaq: PNTG) position is different from other, larger home health companies in the country, mainly in that a substantial portion of its overall revenue comes from senior living. COVID-19 is once again threatening senior care industries, making providers like Pennant more at risk for negative disruption. After all, lower occupancy in […]

  • Carlyle baulks at Vectura auction, but urges shareholders to back its bid

    Private equity group Carlyle has said it won’t raise its offer for respiratory drug specialist Vectura to match a 165p per share offer from tobacco giant Philip Morris International (PMI). The investment firm said its 155p offer was “full and fair” and would not be raised, meaning that it would not enter into a head-to-head […]

  • Harmony Acquires ConSynance’s Asset for the Treatment of Narcolepsy and other Rare Neurological Diseases

    Shots: Harmony to receive $3.5M up front & development and regulatory milestone along with royalties & will acquire full development and commercialization rights globally, Ex- Greater China The acquisition of HBS-102 marks a next-generation therapy after Wakix (pitolisant). Additionally, Harmony plans to build a robust portfolio to treat patients with rare neurological diseases & continue […]

  • Bidding war breaks out for respiratory specialist Vectura

    A flurry of new offers by Philip Morris International (PMI) and private equity firm Carlyle has hiked the value of respiratory medicines company Vectura to £1 more than a billion ($1.4 billion), with the tobacco giant leading the bidding at the latest count. Carlyle first broke ground with a 136 pence per share offer that […]

  • Honor to Aquire Home Instead, Creating $2 Billion Home Care Services Company

    Honor Technology, Inc. has acquired Home Instead, Inc., creating a $2 billion home care services company, the two announced Friday. The deal brings together the largest, highest-touch home care network and the leading home care technology and operations platform, according to the press release. “This is an incredibly exciting moment as we bring together the […]

  • Medtronic to Acquire Intersect ENT for ~$1.1B

    Shots: Medtronic to acquire all outstanding shares of Intersect ENT for $28.25/ share in cash, making a total deal value of ~$1.1B. The transaction is expected to be completed by H1’22 The acquisition will expand Medtronic’s product portfolio which is used in the ENT procedure. Additionally, the acquisition will add a bioabsorbable drug release platform […]

  • Bayer to Acquire Vividion for ~$2B

    Shots: Vividion to receive $1.5B up front & $500M milestone while Bayer to get full rights to Vividion’s discovery platform which consists of chemoproteomic screening technology, a data portal, and a chemistry library. The transaction is expected to close in Q3’21 The acquisition will strengthen Bayer’s drug discovery capabilities & expand it into new modalities. […]

  • LHC Group Touts ‘Record Year’ for Acquired Revenue in 2021

    Excluding 2018 — when it merged with Almost Family — LHC Group Inc. (Nasdaq: LHCG) has had its best year in terms of acquired revenue in its 27-year history during 2021, according to the company. Thanks to a string of home health and hospice deals, LHC Group has doubled its previous goal for acquired revenue […]

  • Bayer bolsters R&D platform with $2bn Vividion takeover

    Bayer headlined its second-quarter results this morning by unveiling a deal to buy Vividion Therapeutics, saying it will boost its ability to develop medicines against targets once considered “undruggable.” Bayer is paying $1.5 billion upfront to claim ownership of Vividion‘s drug discovery platform, which uses chemoproteomics to identify new binding sites on proteins and find […]

  • Transactions: ModivCare to Buy VRI for $315M; Nova Leap Completes Home Care Deal

    ModivCare expands into remote patient monitoring ModivCare Inc. (Nasdaq: MODV), a diversified health care services company with a large personal care business, has signed an agreement to acquire VRI Intermediate Holdings LLC, a provider of remote patient monitoring solutions. Under terms of the agreement, the Denver-based ModivCare will acquire 100% of VRI for a purchase […]

  • EvergreenHealth Home Care, Alivia Ready to Support Choose Home Legislation

    Home-based care leaders are encouraged by the Choose Home Care Act of 2021’s introduction into the U.S. Senate — and what it could mean for the home health industry if it’s ultimately enacted. Brent Korte, Keith Myers and Susan Ponder-Stansel are among them. The trio spoke about the recently introduced legislation Monday at the National […]

  • Addus Doubles Credit Facility to $600M, Maintains Focus on Home Health Expansion

    Addus HomeCare Corporation (Nasdaq: ADUS) has remained laser focused on one goal for some time now: building out all three of its home-based service lines in markets where it is already present. That requires a strategic and aggressive M&A strategy, which Addus has executed in the past year. It plans to continue making moves in […]

  • Sanofi swoops on partner Translate, buying the mRNA firm for $3.2bn

    Sanofi has been forging ever-closer ties with its mRNA partner Translate Bio since the two started working together in 2018, and has now gone all in, offering $3.2 billion to buy the company outright. The $38-per-share deal – a 56% premium to Translate’s recent share price before an after-hours surge in the stock on rumours […]

  • Sanofi to Acquire Translate Bio for ~$3.2B

    Shots: Sanofi to acquire all outstanding shares of Translate Bio for $38.00/share in cash making a total equity value of ~$3.2B with a premium of 30.4% to Translate Bio’s one day prior closing price of $29.15. The acquisition is expected to complete in the Q3’21 The acquisition will utilize mRNA technology to further accelerates Sanofi’s […]

  • BD Acquires Tepha to Boost its Surgical Mesh Portfolio

    Shots: The acquisition will utilize Tepha’s resorbable polymer technology to boost the growth of BD’s surgical mesh portfolio for the repair and regeneration of soft tissues The acquisition also provides strategic vertical integration for BD’s Phasix mesh products & includes Tepha’s GalaFLEX portfolio which is based on the novel P4HB polymer Additionally, an interventional segment […]

  • Humana Sets Stage for Kindred Takeover, Remains Hopeful About a 2022 Return to Normalcy

    Despite still reeling from COVID-19-related headwinds, Humana Inc. (NYSE: HUM) experienced better-than-expected results in its home and provider businesses during the second quarter of 2021. “Our strong operating performance this year is, in part, attributed to our strong partnerships with providers who are delivering high-quality care to our members,” Bruce Broussard, president and CEO of […]

  • Amgen to Acquire Teneobio for ~$2.5B

    Shots: Amgen to acquire all outstanding shares of Teneobio for $900M as up front and $1.6B in cash as contingent milestones to Teneobio equity holders. The transaction is expected to be closed in H2’21 The acquisition will boost Amgen’s abilities to develop innovative therapies and expand its portfolio with the addition of early-stage oncology assets […]

  • ModivCare CEO on $340M CareFinders Deal: Our Goal Is to Build Out a National Platform

    ModivCare Inc. (NYSE: MODV), the non-emergency medical transportation (NEMT) company that’s quickly becoming a major player in the home-based care space as well, announced Monday plans to buy CareFinders Total Care for $340 million. Once the deal is finalized, ModivCare will initially combine the CareFinders business with its existing personal care capabilities from Simplura Health […]

  • Aptar makes digital health play, agreeing deal to buy Voluntis

    Drug delivery specialist Aptar Group has agreed a deal to take a near two-thirds share in Voluntis, a French developer of digital therapeutics (DTx), with a view to taking full control of the company later this year. Illinois-headquartered Apar – which makes inhalers, syringe components, eye drop bottles and other delivery systems for pharmaceuticals, cosmetics […]

  • ModivCare to Acquire CareFinders Total Care in $340M Deal

    Last September, ModivCare Inc. (NYSE: MODV) acquired the large personal care services provider Simplura Health Group for $575 million. Less than nine months later, ModivCare President and CEO ​​Daniel Greenleaf shared a vision for growing his company to a $1 billion home-based care player with a true national footprint. ModivCare has now taken a giant […]

  • PE-Backed Choice Completes 4th Acquisition of 2021, Buys Alpha Home Health and Hospice

    Choice Health at Home has acquired Alpha Home Health and Hospice, further increasing the company’s Oklahoma footprint. Financial terms of the deal were not disclosed. Alpha provides home health and hospice services through five locations in Ada, Ardmore, Oklahoma City, Norman and Pauls Valley. Meanwhile, Tyler, Texas-based Choice is home health, hospice and rehabilitation services […]

  • Help at Home Continues Executing on Growth Strategy, Acquires Community Care Systems

    Help at Home — a private equity-backed provider of home- and community-based care — has acquired Community Care Systems (CCS). Financial terms of the transaction were not disclosed. Founded in the 1908s, the Illinois-based CCS will become part of the Help at Home network, adding 13 additional locations and nearly 6,000 new clients. With nearly […]

  • Lexeo Acquires Stelios to Expands its Gene Therapy Pipeline for Rare Cardiovascular Diseases

    Shots: Lexeo acquires exclusive rights to three preclinical AAV-mediated gene therapy programs for the treatment of rare cardiac disorders, focused on TNNI3-associated HCM & ARVC The acquisition will complement and bolster LEXEO’s advanced pre-clinical gene therapy pipeline with the addition of three novel programs for rare cardiac diseases Additionally, preclinical results from the TNNI3-associated HCM […]

  • ‘Friendly Home Care Competitors’ Family Tree and Evergreen Announce Merger

    Two of the largest concierge-level caregiving, private nursing and care management firms in Houston, Texas, have merged. On Tuesday, Family Tree In-Home Care and Evergreen Private Care of Houston announced that the two companies have formally joined forces. The announcement echoes the increasing amount of consolidation happening in the home-based care space, as operators try […]

  • Home Health Veterans Windley, Strange Hoping to Take Aveanna Above and Beyond $2 Billion

    Rod Windley and Tony Strange have been in business with each other for decades. They continue to be partners today as the chairman and CEO, respectively, of Aveanna Healthcare (Nasdaq: AVAH). From The Healthfield Group Inc. and Gentiva Health Services, Kindred at Home’s predecessor, to Aveanna, Windley and Strange have helped build a handful of […]

  • After Closing Brookdale Deal, HCA Healthcare Continues to Show Home Health Potential

    The day before it officially closed on its deal to acquire 80% of Brookdale Health Care Services (NYSE: BKD), HCA Healthcare (NYSE: HCA) finished a financial quarter that showed significant recovery for the behemoth hospital chain — and then some. As COVID-19 concerns waned for patients, admissions and revenue soared for HCA, which is set […]

  • BioNTech grows in cell therapies, buying Kite’s TCR platform

    BioNTech has found a use for some of the windfall cash it has raked in from its COVID-19 vaccine, agreeing a deal to buy Kite Pharma’s entire neoantigen T cell receptor (TCR) platform for solid tumours, and an associated manufacturing plant. There’s no value attached to the deal – even though BioNTech is a publicly […]

  • Jet Health Lands Signal Home Health & Hospice in Ongoing Expansion Push

    With its latest purchase of San Antonio, Texas-based Signal Home Health & Hospice, Jet Health continues its strategy of co-locating hospice operations with its home health offerings. That has become a calling card for the company, similar to several other home-based care providers. Jet Health announced the Signal deal on Monday without disclosing any financial […]

  • Transactions: Regence BlueShield Teams Up with DispatchHealth; Amedisys Enters New Market

    Health insurer Regence BlueShield has partnered with DispatchHealth to give its members access to hospital-at-home and mobile high-acuity services. “Hospitalizations in the home is a groundbreaking and exciting shift in care delivery,” Dr. Drew Oliveira, senior executive medical director at Regence, said in a press release. “Our partnership with DispatchHealth enables Regence members to receive […]

  • Home Health Industry Must Prepare for Costs of Consolidation

    At Home Health Care News, it seems like we’ve been writing about “the rapidly consolidating home health market” for years. Just check out this story from 2015, for example. There are also these more recent pieces from 2018 and 2019, respectively. In many ways, consolidation — either through agency closures or through M&A activity — […]

  • Eli Lilly to Acquire Protomer Technologies for ~$1B

    Shots: Eli Lilly to acquire Protomer Technologies for ~$1B, with the achievement of future development and commercial milestones Earlier, Lilly led an equity investment in Protomer along with JDRF T1D fund that provides Lilly with 14% ownership of promotor and is currently acquiring the remaining shares of Protomer beyond the initial investment The acquisition will […]

  • Mission Buys Healthy Living Network, Effectively Doubling Its Overall Business

    Mission Healthcare announced Wednesday that it has acquired Healthy Living Network, a multi-state home health provider founded over a decade ago. The deal is the largest acquisition in the San Diego-based Mission’s history, CEO Paul VerHoeve told Home Health Care news. Additionally, by joining forces with Healthy Living Network, Mission effectively doubles its overall business […]

  • Lilly grabs glucose-sensing insulin tech, buying Protomer in $1bn deal

    Eli Lilly bought a stake in Protomer Technologies and its glucose-sensing insulin platform last year, and it must like what it has seen in the programme since then – it has just agreed to buy the company outright.  Pasadena, California-based Protomer is working on proteins that can sense molecular activators in the body and only […]

  • Final hurdle falls as UK backs AZ’s $39bn takeover of Alexion

    The UK’s competition regulator has approved AstraZeneca’s $39 billion acquisition of US-based drugmaker Alexion, without opting for a broader inquiry into the deal. The nod from the Competition and Markets Authority (CMA) after an initial assessment means that it concluded no antitrust risks were associated with the deal. It was the final needed from a […]

  • Addus to Acquire Home Health, Hospice Provider Armada for $29M

    Addus HomeCare Corporation (Nasdaq: ADUS) has signed a definitive agreement to acquire Armada Skilled Home Health and Hospice, further building out its already sizable footprint in the state of New Mexico. It’s yet another step for Addus in its quest to build out home health, hospice and personal care lines in specific markets and states, […]

  • Novo Nordisk bulks up in rare diseases with $1.2bn Prothena deal

    Diabetes giant Novo Nordisk has opened a new front in its rare disease R&D, thanks to an acquisition agreement with Prothena focusing on drugs for ATTR amyloidosis. The Danish drugmaker is paying $100 million upfront for rights to antibody drug PRX004, which is heading for phase 2 trials in cardiomyopathy associated with ATTR amyloidosis, a […]

  • Transactions: Amedisys acquires VNA’s Home Health Assets; AccordCare Expands Medicaid Business

    Amedisys Inc. (Nasdaq: AMED) has completed its purchase of Visiting Nurse Association’s (VNA) assets. Baton Rouge, Louisiana-based Amedisys has a number of in-home care capabilities, including home health, hospice and personal care services. Amedisys also recently acquired Contessa Health for $250 million. The deal gives the company a range of acute-level care services. Meanwhile, VNA […]

  • Big tobacco’s PMI makes another pharma foray with Vectura deal

    Tobacco giant Philip Morris International (PMI) has doubled down on its move into the pharmaceutical sector, following up its recent acquisition of Fertin Pharma with a deal to buy Vectura for around £1 billion ($1.38 billion). PMI is paying 150 pence per share for Vectura, trumping a 139 per share offer from private equity firm […]

  • Another hurdle down as EU clears AstraZeneca’s Alexion takeover

    The European Commission has given competition clearance to the $39 billion acquisition of Alexion by AstraZeneca, leaving the UK as the last remaining obstacle to getting the deal across the line. The EU approval comes after the merger has already been okayed by the US, Japan and a number of other countries around the world, […]

  • Amedisys Looks to Pull Away from the Home Health Pack with ‘No Brainer’ Contessa Deal

    Aging-in-place company Amedisys Inc. (Nasdaq: AMED) on Wednesday announced plans to acquire hospital-at-home pioneer Contessa Health for $250 million. From a nuts-and-bolts perspective, the deal — expected to close later this summer — makes a ton of sense for Amedisys. Among the strategic benefits, for example, it gives the Baton Rouge, Louisiana-based company an unprecedented […]

  • Encompass Health May Be Nearing Home Health, Hospice Spinoff

    Encompass Health Corporation (NYSE: EHC) may be nearing a spinoff — not a sale — of its home health and hospice segment. That avenue looks increasingly likely in light of the company’s recent leadership announcements, industry insiders believe. Last week, Barb Jacobsmeyer was named the new CEO of Encompass Health’s home health and hospice segment, […]

  • Arosa Acquires Family Staffing Solutions

    Arosa — the in-home care company backed by Bain Capital Double Impact and formerly known as Arosa+LivHome — is ramping up its M&A activity in 2021. Toward the beginning of the year, Arosa entered the New Jersey market following the acquisition of Aveanna Concierge Services. On Monday, the in-home care provider announced it has now […]

  • AccentCare Enters Two New Markets with Purchase of Southeastern Health Care at Home

    AccentCare announced Monday that it has purchased Southeastern Health Care at Home from private equity firm Geneva Glen Capital. Southeastern Health Care at Home is the largest privately-owned home health services provider in Pennsylvania. In addition to home health care, the company delivers hospice and mobile primary care services, plus palliative and wound care services. […]

  • Pennant Acquires First Call Hospice; Humana Grows CenterWell Footprint

    Pennant adds end-of-life care provider The Pennant Group Inc. (PNTG) has acquired the assets of First Call Hospice, an end-of-life care provider that operates in Sacramento, California. Financial terms of the acquisition, effective June 16, were not disclosed. The Eagle, Idaho-based Pennant is the parent organization of a group of affiliated home health, hospice, home […]

  • Help at Home Reportedly Planning to Go Public by Year’s End

    Help at Home — a provider of home- and community-based services (HCBS) — is considering going public. The Chicago-based company has even selected banks to help it prepare for an IPO later this year, Bloomberg News reported. More providers are considering public exits thanks to an increasing demand for home-based care, promising outlooks for public […]

  • Roivant spinout Datavant merges with Ciox to form $7bn health data giant

    Datavant and Ciox Health have agreed a merger that will create what they claim will be the largest health data company operating in the US market. The combined company – which will take the Datavant name – will be worth around $7 billion and have annual revenues of around $700 million, according to the two […]

  • How Home Health Care Helped Shape the $34B Medline Megadeal

    A group of private equity firms have reached an agreement to acquire a controlling stake in Medline Industries Inc., a major player in the medical-supply space that works across the continuum of care. Announced Saturday, the deal reportedly places a $34 billion enterprise value on the Northfield, Illinois-based Medline. While the megadeal likely won’t directly […]

  • Bayer props up sagging radionuclide business with Noria acquisition

    Bayer has agreed to buy Noria Therapeutics and its subsidiary PSMA Therapeutics, adding to its pipeline of radionuclide drugs for cancer as sales of its lead product in the category – Xofigo – continue to decline.  Just over three years ago, Bayer was forced to concede that its blockbuster expectations for Xofigo (radium Ra 223 […]

  • MorphoSys to Acquire Constellation Pharmaceuticals for ~$1.7B

    Shots: MorphoSys to acquire all of the outstanding shares of Constellation’s common stock for $34.00/ share in cash making a total equity value of $1.7B. The transaction is expected to close in Q3’21 The acquisition will bolster Morphosys’ position in hematology-oncology & accelerates growth strategy with the addition of Constellation’s Pelabresib (CPI-0610) & CPI-0209 Additionally, […]

  • Addus Focused on Sourcing New Home Health Acquisitions, Improving Applicant-Conversion Rates

    The COVID-19 public health emergency has solidified the home as a viable and effective care setting. That, in turn, has led to meaningful opportunities for home-based care providers, especially those with diversified service lines. Addus HomeCare Corporation (Nasdaq: ADUS) is a prime example. The company’s leadership team discussed the pandemic and its lasting impacts during […]

  • LHC Group Bides Its Time on Home Health M&A, Inks Another Hospice Deal

    In-home care powerhouse LHC Group Inc. (Nasdaq: LHCG) has reached an agreement to acquire Heart of Hospice, an end-of-life care provider with locations in five states. Financial terms of the deal were not disclosed. The transaction announcement comes a week after LHC Group unveiled similar plans to buy Idaho-based Heart ‘n Home Hospice for an […]

  • MorphoSys offers $1.7bn for Constellation, but investors see stars

    Shares in German biotech MorphoSys have gone on the slide after it announced a $1.7 billion deal to buy its US rival Constellation Pharma and its pipeline of cancer and haematology therapies. MorphoSys said the $34 per share deal would accelerate growth by adding two clinical-stage drug candidates, namely BET inhibitor pelabresib (CPI-0610) in phase […]

  • Searchlight Capital Lands Majority Stake in Care Advantage

    Funds advised by Searchlight Capital Partners have reached an agreement to acquire a majority stake in Care Advantage, one of the largest in-home care companies in the Mid-Atlantic region. Terms of the transaction were not disclosed. Founded over three decades ago, Care Advantage offers a range of in-home care services to patients across Virginia, Maryland, […]

  • Ashfield Engage acquires US consulting firm Nuvera LLC

    Ashfield Engage has completed the acquisition of Nuvera, a US-based healthcare consulting firm specialising in patient support programmes. Ashfield Engage and Nuvera will offer integrated specialist support and services including late-phase clinical trial experience, implementation and post-commercialisation satisfaction benchmarking and service optimisation. Nareda Mills, global president, patient solutions, Ashfield Engage said the combined expertise of […]

  • Aveanna Details Big Plans for Home Health M&A in First Official Earnings Call

    Fresh off of its market debut last month, Aveanna Healthcare Holdings, Inc. (Nasdaq: AVAH) is throwing its weight behind home health. Since going public, the company has made moves to position itself as a major player within the home health space. Aveanna plans to aggressively pursue home health M&A opportunities, Rod Windley, executive chairman of […]

  • Vectura agrees $1.4bn takeover by private equity group Carlyle

    Vectura has agreed to a £1.55 per share takeover by US private investment company Carlyle, which values the UK drug delivery specialist at £958 million ($1.4 billion).  The acquisition of one of the UK’s biggest biotech companies comes as Vectura is in the midst of a business restructuring that has seen it pivot away from […]

  • DispatchHealth Announces New Health System Partnerships; LHC Group Enters Oregon Hospice Market

    DispatchHealth partners with two new health systems The in-home medical care provider DispatchHealth on Tuesday announced partnerships with Eastern Connecticut Health Network (ECHN) and Waterbury Health. The partnerships revolve around bringing patients same-day, at-home medical care. Denver-based DispatchHealth partners with health systems and payers to offer an array of services within the home. The company’s […]

  • UK competition watchdog probes AstraZeneca, Alexion merger

    The antitrust authority in the UK has launched an investigation into the proposed $39 billion takeover of US firm Alexion by AstraZeneca. The Competition and Markets Authority (CMA) is starting the first phase of the probe today, and said it should wrap it up by 21 July, deciding at that point whether to start a […]

  • Zing Health Announces Expansion, Sets Sights on Larger Home-Based Care Partnerships

    Zing Health Enterprises, a Chicago-based Medicare Advantage provider, has announced plans to expand to over 30 additional states through its pending acquisition of Lasso Healthcare. The two entities ultimately aligned on a deal because of their like-minded approach, according to Dr. Eric Whitaker, the CEO and founder of Zing Health. Lasso Healthcare and Zing Health […]

  • How a Capital Gains Tax Hike Could Affect the Home-Based Care M&A Market

    The M&A market is heating up again now that uncertainty tied to the COVID-19 crisis is waning. Another factor that could increase transactions and shift the market, though, has nothing to do with home-based care. Instead, it’s President Joe Biden’s proposed increase to the capital gains tax. Broadly, a capital gains tax is applied to […]

  • Under-pressure GSK sells stake in respiratory diseases partner Innoviva

    GlaxoSmithKline has sold its entire stake in its respiratory partner Innoviva, raising $392 million and simplifying its business ahead of a split into two. GSK is pushing ahead with a split into an innovative drugs business and a consumer healthcare firm, while the spectre of activist investor Elliott Management hangs over it. The fund run […]

  • Medalogix Merges with Muse Healthcare, Gets Backing from Vistria and LHC Group

    Medalogix was already one of the market leaders in home health predictive analytics. It has now gotten what appears to be another boost. That boost comes in the form of three new developments: a merger, a private equity investment and an investment from yet another publicly traded home health care giant. On Wednesday, the Chicago-based […]

  • BlackTree, Simione Unveil ‘SimiTree’ Following Private Equity-Backed Merger

    The post-acute care space has been undergoing a wave of consolidation for the past few years. And as more providers come together, the businesses that serve them are beginning to do the same. The newest example of that trend came Tuesday, when the Connecticut-based Simione Healthcare Consultants and Pennsylvania-based BlackTree Healthcare Consulting revealed plans to […]

  • Why SPACs Could Shake Up the Home-Based Care M&A Environment

    Special purpose acquisition companies (SPACs) have risen to immense popularity in the past 12 months. Many are becoming more intrigued by senior-focused investments as well. Ultimately, that could lead to a shift in the home-based care M&A environment. SPACs — sometimes referred to as “blank-check companies” — offer an alternative to the traditional route of […]

  • HouseWorks Acquires Care Management Company Intervention Associates

    HouseWorks — the large, independent home care organization that also runs a home-modification business — is adding another important senior care tool to its toolbox. The Boston-based HouseWorks announced Monday that it has acquired Intervention Associates, a care management company that currently serves the Greater Philadelphia area. Financial terms of the acquisition were not disclosed. […]

  • Charles River to Acquire Vigene Biosciences for $292.5M

    Shots: Charles River Laboratories to acquire Vigene in all cash transaction for $292.5M. In addition to the initial purchase price, the transaction includes contingent additional payments of up to $57.5M based on future performance The transaction is expected to be close in Q3’21. The acquisition will allow Charles River to boost its gene therapy capabilities […]

  • PerkinElmer to Acquire Immunodiagnostic Systems Holdings for ~$155M

    Shots: PerkinElmer to acquire IDS in all cash transactions for ~$155M. The transaction is expected to be completed in Q3’21 The acquisition will allow PerkinElmer to foster its overall Diagnostics business and specifically its immunodiagnostics segment The acquisition will integrate PerkinElmer’s channel expertise and testing capabilities with IDS’ chemiluminescence products in endocrinology, autoimmunity, and infectious […]

  • AMN Healthcare Buys Synzi for $42.5M; Pennant Acquires Texas Home Health Provider

    AMN scoops up Synzi Staffing powerhouse AMN Healthcare Services Inc. (NYSE: AMN) has completed its $42.5 million all-cash acquisition of full-service virtual care management company Synzi. The Dallas-based AMN offers workforce and staffing solutions across the health care continuum, from acute care hospitals and urgent care centers to home health agencies. It also delivers its […]

  • Long-Term Clients, Referral Sources Give Home Care Sellers an M&A Edge

    In April, home care provider Family Tree In-Home Care acquired HomeCare of the Rockies. And while it seems like just another transaction, from the buyer’s perspective, it was anything but. The acquisition was Family Tree’s first since the pandemic began. Its growth strategy plans were severely delayed by the COVID-19 crisis, but the trends in […]

  • Encompass Health CEO: There’s Pent-Up Demand for Home Health Services

    Encompass Health Corp. (NYSE: EHC) is actively evaluating ways to strategically reposition its home health and hospice segment, which also needs a new leader. The search is under way for that new segment CEO, with current CEO April Anthony — its original founder — set to step down in June. Even with all of that […]

  • Visiting Nurse Association to Sell Home Health, Hospice Operations to Amedisys

    Amedisys Inc. (Nasdaq: AMED) expected to do plenty of dealmaking heading into 2020 and Year 1 of the Patient-Driven Groupings Model (PDGM). Those plans, however, were largely put on pause for the Baton Rouge, Louisiana-based home health, hospice and personal care services company due to the COVID-19 pandemic. While Amedisys remained active on the M&A […]

  • InnovAge CEO: ‘We Have a Couple of Irons in the Fire’

    Even though InnovAge (Nasdaq: INNV) is already one of the largest Program of All-Inclusive Care for Elderly (PACE) providers in the U.S., the company has plans to go after an even bigger piece of the pie. Maureen Hewitt, president and CEO of InnovAge, talked about the company’s multi-pronged growth strategy on Monday during a conference […]

  • Home Care Innovator Lifesprk to Acquire Senior Living Operator Tealwood

    Lifesprk — the whole-person senior services company based in Minnesota — has added a new page to its innovative playbook. On top of being a fully integrated provider of home health, hospice, primary care and other senior-focused services, Lifesprk is also now a bona fide senior living operator. It holds that distinction after announcing the […]

  • Allergan Aesthetics to Acquire Soliton and its Resonic Device for ~$550M

    Shots: Soliton to receive $22.60 /share in cash for its all outstanding share making the total deal value $550M The acquisition adds Soliton’s Rapid Acoustic Pulse technology platform to Allergan Aesthetics’s portfolio for improvement in appearance of cellulite in the buttocks and thighs by using rapid high-frequency sound waves to disrupt targeted cellular structures and […]

  • Simplura Is First Block in ModivCare’s Mission to Build $1B Personal Care Business

    Ever since ModivCare Inc. (Nasdaq: MODV) entered the personal care space with a major acquisition last year, it has been working to solidify its place in the larger social determinants of health movement. ModivCare completed its personal care-focused acquisition of Simplura last November. The acquisition was an all-cash transaction that placed an enterprise value of […]

  • Walmart to acquire telehealth firm MeMD

    Walmart is to acquire telehealth provider MeMD, the companies announced as the retail giant continues with its move into digital healthcare. In statement, Walmart said it wants to use data and technology to improve engagement with healthcare services, health equity and outcomes. Over the coming months the acquisition will allow Walmart to provide access to […]

  • Addus Encouraged by Vaccine Progress, New HCBS Policies

    Typically, when executives talk about their companies “having to weather the storm,” they’re speaking figuratively. That wasn’t the case for Addus HomeCare Corporation (Nasdaq: ADUS) on Tuesday. Addus CEO and Chairman Dirk Allison talked about the negative impact that the February winter storms had on the home-based care provider’s business during the company’s Q1 2021 […]

  • Roivant Going Public Via MAAC SPAC Merger for ~$7.3B

    Shots: Roivant signs a SPAC merger with MAAC for ~7.3B including $411M in cash in the MAAC trust account and $200M in PIPE stock at $10.00/share. The transaction is expected to deliver ~$611M to fund discovery and development programs and is expected to close in Q3’21 Roivant equity holders and Patient Square Capital have agreed […]

  • LHC Group Expands Texas Joint Venture; Anthem Completes myNEXUS Acquisition

    LHC Group announces JV expansion LHC Group Inc. (Nasdaq: LHCG) as well as partners Texas Health Resources and Methodist Health System are expanding their joint venture in Texas. The three health care organizations announced on Thursday that they’re purchasing and sharing ownership of Regent Home Health, a provider that currently serves patients and families in […]

  • AZ posts solid Q1 results as Alexion merger looms

    AstraZeneca’s not-for-profit coronavirus vaccine has bit into margins in Q1, although revenues were ahead of expectations as the company heads towards completion of its $39bn acquisition of Alexion.  The company posted Q1 product sales of $7.26bn, ahead of consensus forecasts of around $6.84 billion, with total revenues up 15% compared with last year’s Q1 to […]

  • Looking to Build Market Share, Amedisys Rolls Out SNF-at-Home Pilot Program

    Amedisys Inc. (Nasdaq: AMED) hasn’t been shy about the company’s plans to gain an even larger share of business from other post-acute care operators. With that in mind, the company has been focused on setting up shop in the SNF-at-home space, pairing skilled home health care with non-medical personal care services. Those efforts have now […]

  • Alcon to Acquire Exclusive US Commercialization Rights to Novartis’ Simbrinza

    Shots: Novartis to receive $355M following the closure of acquisition, which is expected to occur in Q2’21. The acquisition expands existing Alcon’s ophthalmic portfolio and strengthens its footprints in the US The companies will initiate a transition period where Novartis will continue to sell Simbrinza and transfer the profit to Alcon. Following the transition period, […]

  • Pfizer Acquires Amplyx to Expand its Infectious Disease Portfolio

    Shots: The acquisition expands the anti-infectives pipeline with the addition of Amplyx’s P-II candidate, Fosmanogepix (APX001) which is being evaluated in both IV and oral formulations for the treatment of patients with invasive fungal infections Pfizer also retains ownership of the Amplyx early-stage pipeline, including antiviral (MAU868) and antifungal (APX2039) therapies. The acquisition follows an […]

  • Why Humana Believes It Can Do Home Health Care Better

    Humana Inc. (NYSE: HUM) believes it can deliver home health services better than traditional providers do today. More than any other reason, that’s fundamentally why it’s accelerating its in-home care strategy by acquiring 100% of home health giant Kindred at Home for a “bargain” purchase price of $5.7 billion — the company’s largest acquisition ever. […]

  • DispatchHealth Makes First Acquisition, Acquires Mobile Imaging Company

    DispatchHealth has officially transitioned from “up-and-coming startup” to “active acquirer.” The company announced Tuesday that it has made its first-ever purchase by landing Professional Portable X-Ray (PPX), a mobile imaging provider. Financial terms of the transaction were not disclosed. Denver, Colorado-based DispatchHealth offers hospital-at-home and mobile high-acuity services through its emergency medicine-trained teams. It currently […]

  • PE-Backed Valeo Acquires Post-Acute Care Business; BrightSpring Finalizes Abode Deal

    Valeo Home Health lands Hearts for Hospice & Home Health Valeo Home Health & Hospice has acquired Hearts for Hospice & Home Health from Abode Healthcare. Valeo is PE-backed provider based in Millcreek, Utah, that provides a mix of post-acute care services Strategically, the acquisition increases Valeo’s presence in Utah, as Hearts for Hospice & […]

  • Encompass Health Pens Deal to Acquire Home Health Assets of Frontier

    Ahead of this week’s upcoming earnings call, Encompass Health Corp. (NYSE: EHC) has locked in an agreement to acquire the home-based care assets of Frontier Home Health and Hospice. The company announced the news Monday. The financial terms of the deal were not disclosed. Birmingham, Alabama-based Encompass Health delivers care in both facility- and home-based […]

  • Indigo Medical merges with imc group

    Indigo Medical, a provider of material review, medical signatory approval services and medical communication for global pharmaceutical and biopharma companies, is joining imc group with the backing of pan-European investor Waterland Private Equity. In a statement the companies said the merger will help imc provide a one-stop service for clients across seven core divisions: Medical […]

  • SparingVision Acquires GAMUT Therapeutics to Expands its Novel Ocular Disease Pipeline

    Shots: The acquisition expands SparingVision’s ocular genomic medicine pipeline with the addition of GAMUT’s lead product SPVN20, which is a novel, mutation-agnostic gene therapy, focuses on restoring the function of dormant cone cells in the retina. The acquisition is expected to close in Q2’21 SparingVision plans to evaluate the therapeutic synergy with a combination of […]

  • ThermoFisher to Acquire PPD for ~$17.4B

    Shots: ThermoFisher to acquire PPD for $47.50/share making a total purchase price of $17.4B along with ~$3.5B of net debt with a premium of ~24% to the closing price of PPD’s common stock as of Apr 13, 2021. The transaction is expected to be completed by the end of 2021 The acquisition expands ThermoFisher’s service […]

  • Microsoft puts AI at heart of digital health strategy with Nuance deal

    Microsoft has made its aspirations in digital health clear with a whopping $19.7 billion deal to buy Nuance Communications and its artificial intelligence platform for speech recognition that is increasingly being used for clinical applications.  The $56 per share deal is all about increasing Microsoft’s position in digital health, and represents a hefty multiple on […]

  • Amedisys, Charter Keep Home Health M&A Train Rolling

    The home health dealmaking train keeps on rolling, with the latest transactions coming from Amedisys Inc. (Nasdaq: AMED) and Charter Health Care Group, a private equity-backed post-acute care provider. On Wednesday, the Baton Rouge, Louisiana-based Amedisys announced it signed a definitive agreement to acquire the regulatory assets of a home health provider operating in Randolph […]

  • Avantor to Acquire Ritter and its Affiliates for ~$1.06B

    Shots: Avantor to acquire Ritter and its affiliates in an all-cash transaction with an up front equity purchase price of ~ $1.06B along with additional payments following the achievement of milestones. The transaction is expected to be completed in Q3’21 The acquisition expands Avantor’s offering for diagnostic and drug discovery workflows The acquisition integrates Ritter’s […]

  • DiaSorin to Acquire Luminex for ~$1.8B

    Shots: DiaSorin to acquire Luminex for $37.00/ share in an all-cash transaction, with 23% premium based on closing stock price of Luminex on 24 Feb, 2021, making a total equity value of $1.8B The acquisition will boost DiaSorin’s presence in the molecular diagnostics space in the US with the addition of Luminex’s molecular diagnostics multiplexing […]

  • Microsoft to Acquire Nuance for ~$19.7B

    Shots: Microsoft to acquire all outstanding shares of Nuance for $56.00/ share, making a total deal value of $19.7B in cash with a premium of 23% to Nuance closing price on Apr 09, including its net debt. The transaction is expected to close in 2021 The acquisition builds on Microsoft’s efforts to deliver new cloud […]

  • Report: Fewer health system M&A deals in Q1 2021 offset by larger transactions

    Though the number of merger and acquisition deals in the first quarter of 2021 fell below historical averages, the size of the deals was far bigger than the same period last year, a new report from Kaufman Hall shows. The total transacted revenue was $8.8 billion, the second-highest Q1 figure in the last five years.

  • Q1 2021 Health IT/Digital Health PC/VE, M&A, IPOs/ SPACs Activity

    The first quarter of 2021 has been one of investor optimism as the vaccine rollout continues ahead of expectations and economic activity begins to accelerate in response.  Within the Health IT industry, the already strong investment and M&A trends seen in 2020 have only accelerated.  Over the course of the quarter, we observed $7 billion in private […]

  • Fishawack buys health economics consultancy PRMA

    UK comms agency Fishawack Health has acquired the health economics outcomes research (HEOR) consultancy PRMA Consulting. PRMA has offices across Europe, Asia and the US and adds expertise in Asia-Pacific and European markets to the company’s market access offering in North America. The company said that the acquisition will allow it to offer a HEOR […]

  • Sanofi to Acquire Tidal Therapeutics for ~$470M

    Shots: Sanofi to acquire Tidal Therapeutics for $160M up front and ~ $310M following the achievement of certain milestones The acquisition will add Tidal’s innovative mRNA-based research platform with applications in oncology, immunology, and other disease areas With its acquisition, Sanofi will further develop the technology platform to expand its research capabilities in immuno-oncology and […]

  • Hologic to Acquire Mobidiag for ~ $795M

    Shots: Hologic to acquire Mobidiag for ~$795M which includes ~$714M in cash for Mobidiag’s equity and debt of $81M. The acquisition is expected to close in Q4’21 The acquisition will accelerate Hologic’s global footprints by enabling it to expand into the large, fast-growing acute care adjacency with a near-patient testing solution that offers ease of […]

  • Health Care-Focused PE Firm RiverGlade Capital Acquires Home Helpers

    Home care M&A experts knew that the dealmaking dominoes would start to tumble in 2021, pushed over by the recent agreement between Senior Helper and Advocate Aurora Enterprises. They didn’t know how fast that chain reaction would be, however. On Thursday, H.H. Franchising Systems Inc. — the Cincinnati-based company that operates Home Helpers Home Care […]

  • PE Players Getting More Collaborative in Home Care Dealmaking

    The recent upswing in home care dealmaking activity driven by private equity continues. It appears PE buyers are starting to get more collaborative, too. On Tuesday, a consortium of private equity firms came together to acquire Aging With Comfort, an independently owned Philadelphia-based home care agency that provides personal care assistance for elderly and disabled […]

  • Senior Helpers Likely to Be the First of Many Home Care Dominoes to Fall in 2021

    Last week, the investment arm of Advocate Aurora Health acquired Senior Helpers, the giant home care franchise organization that domestically operates across 44 states. Advocate Aurora Enterprises pulled the trigger on the Maryland-based Senior Helpers as part of its three-pronged investment thesis around aging, parenthood and well-being. According to a report from PE Hub, Advocate’s […]

  • Sorrento to Acquire ACEA Therapeutics for ~$488M

    Shots: ACEA to receive up to ~$38M in shares of Sorrento common stock, $450M as additional payments upon the achievement of clinical & sales milestones along with 5 – 10% royalties based on annual sales of each product. The acquisition is expected to close in Q2’ 21 The acquisition includes Abivertinib, AC0058, AC0939, and ACEA’s […]

  • Mission Healthcare Purchases Loma Linda University Medical Center’s Home Health Segment

    Mission Healthcare has acquired Loma Linda University Medical Center Home Health in Southern California. Loma Linda University Medical Center Home Health is a part of Loma Linda University Health, which includes eight professional schools, six hospitals and a network of more than 900 faculty physicians. Meanwhile, San Diego, California-based Mission Healthcare is one of the […]

  • Aveanna Files for $100M IPO, Announces Major Expansion Plans

    Aveanna Healthcare Holdings Inc. — a large and rapidly growing in-home care company that historically has specialized in caring for complex pediatric patients — is attempting to go public. The Atlanta-based home health provider announced plans to raise $100 million in an initial public stock offering on Thursday. In its paperwork, Aveanna also revealed an […]

  • The Pennant Group Acquires Colorado Home Health Agency

    After announcing that it has aspirational growth plans for 2021, The Pennant Group Inc. (Nasdaq: PNTG) delivered on Thursday, as it announced the acquisition of a Colorado home health agency. The Eagle, Idaho-based Pennant Group is the parent company of affiliated home health, hospice and senior living companies. Included in its network are 84 home […]

  • Precision Value & Health acquires Across Health

    Pharma marketing specialist Precision Value & Health has acquired the specialist communications consultancy Across Health. Across Health is a leading global omnichannel engagement consultancy focused on providing clients an analytical and evidence-based framework for commercial strategy, execution, and resource optimisation. The company’s solutions are based around its proprietary Navigator365 product suite, which more than 40 […]

  • Immunai Acquire Dropprint Genomics to Expand its Target Discovery Capabilities

    Shots: Immunai acquires the Dropprint Genomics and also expand its team with the hiring of new experts in immunology, single-cell technologies and machine learning The acquisition and the new hiring will advance the Immunai’s work in single cell functional genomics to support discovery, prioritization, and development of new therapies and drug combinations The acquisition happened […]

  • Anthem to Buy Home-Based Care Management Company myNEXUS

    Anthem Inc. (NYSE: ANTM) is bolstering its home-based care capabilities. The Indianapolis-based health insurer announced Wednesday that it has entered into an agreement to buy myNEXUS Inc., a technology-enabled company that manages home-based care for payers. Financial terms of the agreement were not disclosed. “Providing timely care for members in their homes allows for both […]